Search Orphan Drug Designations and Approvals
-
Generic Name: | Dimethyl sulfoxide |
---|---|
Date Designated: | 11/22/1994 |
Orphan Designation: | Treatment of increased intracranial pressure in patients with severe, closed-head injury, also known as traumatic brain coma, for whom no other effective treatment is available. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Abela Pharmaceuticals, Inc. 21581 Midcrest Drive Lake Forest, California 92630 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-